Lower riskDrug recall · FDA · Published July 11, 2024
Healthy Living Acetaminophen Tablets Recall: Missing Manufacturer Label
Aurobindo Pharma recalls 100-count Healthy Living Acetaminophen, Aspirin and Caffeine tablets due to missing manufacturer label. This affects some bottles sold in the US with specific lot numbers.
“Healthy Living Acetaminophen Tablets Recall: Missing Manufacturer Label.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32589-healthy-living-acetaminophen-tablets-recall-missing-manufacturer-label. Based on FDA recall #D-0641-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0641-2024%22&limit=1).
Aurobindo Pharma USA Inc recalled Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine tablets due to missing manufacturer labels that include drug facts information, the FDA said on July 11, 2024. The recall affects 240 bottles distributed in New Jersey, New York and Pennsylvania.
Some bottles are missing the manufacturer's label that includes the drug facts information. The FDA has classified this recall as Class I.
Context
GovInfoNow's records show Aurobindo Pharma USA Inc has 32 other recalls on record since April 9, 2013. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall: Missing Label Hazard (April 16, 2026), Aero Healthcare Acetaminophen Caffeine Capsules: Label Mix-Up in Outer Box (Oct. 17, 2025) and Ascend Laboratories recalls Amlodipine/Olmesartan tablets with low drug content (July 8, 2026). FDA's FAERS adverse-event database contains 115 adverse-event reports naming this product, all years, 95 of them marked serious and 26 listing a death.
How to tell if you have this one
Check for the label with the manufacturer information on the bottle. The recalled product has the lot number AC2523005A and was distributed by Aurohealth LLC in the US.
Brand
Aurobindo Pharma
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Label
Look for the manufacturer label that includes drug facts information on the bottle.
Where it went and when
Where it was distributed
Distributed in 3 states.
Listed by the agency
Not listed
FDA distribution: “NJ, NY & PA” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: New Jersey, New York, Pennsylvania.
Recall timeline
FDA published this recall 48 days after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0641-2024 (July 11, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0641-2024 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.